DrugPatentWatch Database Preview
Drugs in Development Information for Sulodexide
» See Plans and Pricing
What is the development status for investigational drug Sulodexide?
Sulodexide is an investigational drug.
There have been 16 clinical trials for Sulodexide.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Albuminuria. The leading clinical trial sponsors are Keryx Biopharmaceuticals, Collaborative Study Group (CSG), and Steno Diabetes Center.
There are one hundred and five US patents protecting this investigational drug and four hundred and sixty-three international patents.
Summary for Sulodexide
| US Patents | 105 |
| International Patents | 463 |
| US Patent Applications | 273 |
| WIPO Patent Applications | 357 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-09-01) |
| Vendors | 5 |
Recent Clinical Trials for Sulodexide
| Title | Sponsor | Phase |
|---|---|---|
| Suloexide in the Treatment of Early Stages of COVID-19 | Alfasigma S.p.A. | Phase 2/Phase 3 |
| Suloexide in the Treatment of Early Stages of COVID-19 | Clinedem | Phase 2/Phase 3 |
| Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) | Arianna Anticoagulazione Foundation | Phase 3 |
Clinical Trial Summary for Sulodexide
Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide
US Patents for Sulodexide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulodexide | Start Trial | Methods, kits and devices for promoting cardiac regeneration | Yeda Research and Development Co. Ltd. (Rehovot, IL) Victor Chang Cardiac Research Institute (Darlinghurst, AU) | Start Trial |
| Sulodexide | Start Trial | Nucleic acid vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Polynucleotides encoding immune modulating polypeptides | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Combination PIV3/hMPV RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulodexide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulodexide | Australia | AU2015249553 | 2034-04-23 | Start Trial |
| Sulodexide | Brazil | BR112016024644 | 2034-04-23 | Start Trial |
| Sulodexide | Canada | CA2946751 | 2034-04-23 | Start Trial |
| Sulodexide | China | CN106659803 | 2034-04-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
